GlassScriptPhysician profile
Mitchell J Bosman
NPI 1922460070
$7,777.74
in general payments reported to CMS, 2019-2025
20 companies · $1,427 in 2025
The $1,427 reported for 2025 was more than what 95% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,614 · 2021: $2,059 · 2022: $946 · 2023: $893 · 2024: $838 · 2025: $1,427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,992 · Travel and Lodging: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,992.46 |
| Travel and Lodging | $166.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $4,469.71 | 2020-2025 | Proclaim, Eterna, Ionicrf |
| Boston Scientific Corporation | $615.42 | 2020-2025 | General - Pain Management, Intracept |
| Medtronic USA, INC. | $412.82 | 2020 | |
| Nevro Corp. | $402.73 | 2020-2021 | |
| Relievant Medsystems, INC. | $349.95 | 2021-2023 | Intracept |
| Saluda Medical Americas, INC. | $248.63 | 2022-2025 | Evoke Scs, Evoke |
| Medtronic, INC. | $186.50 | 2021-2025 | Inceptiv, Intellis Adaptivestim |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $182.78 | 2024-2025 | Relistor, Trulance |
| Abbvie INC. | $160.93 | 2024-2025 | |
| Nalu Medical, INC. | $154.35 | 2021-2024 | Nalu Neurostimulation System |
| Valinor Pharma, LLC | $133.35 | 2023-2025 | Movantik |
| Painteq LLC | $129.33 | 2024 | Painteq |
| Vertos Medical, INC. | $74.29 | 2023-2024 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $73.53 | 2025 | |
| Biotronik Nro, INC. | $56.47 | 2025 | Prospera |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $27.85 | 2020 | |
| Stryker Corporation | $27.43 | 2025 | Mild Device Kit |
| Spr Therapeutics, INC | $25.75 | 2021-2024 | Sprint Pns System |
| Si-Bone, INC. | $25.29 | 2024 | |
| Ibsa Pharma INC. | $20.63 | 2023 | Licart, Tirosint |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Bosman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.